JP2002356472A5 - - Google Patents

Download PDF

Info

Publication number
JP2002356472A5
JP2002356472A5 JP2001309559A JP2001309559A JP2002356472A5 JP 2002356472 A5 JP2002356472 A5 JP 2002356472A5 JP 2001309559 A JP2001309559 A JP 2001309559A JP 2001309559 A JP2001309559 A JP 2001309559A JP 2002356472 A5 JP2002356472 A5 JP 2002356472A5
Authority
JP
Japan
Prior art keywords
group
cyclic
lower alkyl
substituted
monocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001309559A
Other languages
English (en)
Japanese (ja)
Other versions
JP4329291B2 (ja
JP2002356472A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001309559A priority Critical patent/JP4329291B2/ja
Priority claimed from JP2001309559A external-priority patent/JP4329291B2/ja
Publication of JP2002356472A publication Critical patent/JP2002356472A/ja
Publication of JP2002356472A5 publication Critical patent/JP2002356472A5/ja
Application granted granted Critical
Publication of JP4329291B2 publication Critical patent/JP4329291B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001309559A 2000-10-06 2001-10-05 含窒素五員環化合物 Expired - Fee Related JP4329291B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001309559A JP4329291B2 (ja) 2000-10-06 2001-10-05 含窒素五員環化合物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2000308528 2000-10-06
JP2000-308528 2000-10-06
JP2000-312562 2000-10-12
JP2000312562 2000-10-12
JP2001-99251 2001-03-30
JP2001099251 2001-03-30
JP2001309559A JP4329291B2 (ja) 2000-10-06 2001-10-05 含窒素五員環化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005105732A Division JP2005200427A (ja) 2000-10-06 2005-04-01 含窒素五員環化合物

Publications (3)

Publication Number Publication Date
JP2002356472A JP2002356472A (ja) 2002-12-13
JP2002356472A5 true JP2002356472A5 (US07816364-20101019-C00101.png) 2005-09-15
JP4329291B2 JP4329291B2 (ja) 2009-09-09

Family

ID=27481686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001309559A Expired - Fee Related JP4329291B2 (ja) 2000-10-06 2001-10-05 含窒素五員環化合物

Country Status (1)

Country Link
JP (1) JP4329291B2 (US07816364-20101019-C00101.png)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803754B2 (en) 2005-01-10 2010-09-28 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US7816364B2 (en) 2006-04-11 2010-10-19 Arena Pharmaceuticals, Inc. GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
US7833730B2 (en) 2006-04-11 2010-11-16 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
US7838254B2 (en) 2008-04-07 2010-11-23 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464335A3 (en) * 2003-03-31 2007-05-09 Taisho Pharmaceutical Co. Ltd. Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
EP1695969A4 (en) * 2003-12-11 2008-11-26 Mitsubishi Tanabe Pharma Corp ALPHA-AMINO-ACID DERIVATIVES AND THEIR USE AS MEDICINE
NZ548440A (en) 2004-02-05 2009-07-31 Kyorin Seiyaku Kk Bicycloester derivative inhibitng DPP-IV for treatment of diabetes or similar
KR20060129021A (ko) * 2004-02-18 2006-12-14 교린 세이야꾸 가부시키 가이샤 비시클로아미드 유도체
EP1719757B1 (en) * 2004-02-27 2013-10-09 Kyorin Pharmaceutical Co., Ltd. Bicyclo derivative
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
WO2006014482A1 (en) * 2004-07-08 2006-02-09 Boehringer Ingelheim Pharmaceuticals, Inc. Pyrimidine derivatives useful as inhibitors of pkc-theta
ATE553077T1 (de) * 2004-07-23 2012-04-15 Nuada Llc Peptidaseinhibitoren
AU2005293266B2 (en) * 2004-10-12 2011-09-29 Glenmark Pharmaceuticals S.A. Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and process for their preparation
CN101395131B (zh) 2006-03-08 2012-11-14 杏林制药株式会社 氨基乙酰基吡咯烷甲腈衍生物的制备方法及其制备中间体
JP2009190971A (ja) * 2006-06-06 2009-08-27 Mitsubishi Tanabe Pharma Corp ２−シアノピロリジン誘導体
ATE550319T1 (de) 2007-03-22 2012-04-15 Kyorin Seiyaku Kk Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
EP2231687A4 (en) * 2008-01-10 2012-11-14 Sun Pharma Advanced Res Co Ltd NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
EP2322499A4 (en) 2008-08-07 2011-12-21 Kyorin Seiyaku Kk PROCESS FOR PRODUCING A BICYCLOÝ2.2.2¨OCTYLAMINE DERIVATIVE
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
BR112012025592A2 (pt) 2010-04-06 2019-09-24 Arena Pharm Inc moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
CA3058806A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. Ppar.gamma. agonist for treatment of progressive supranuclear palsy

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803754B2 (en) 2005-01-10 2010-09-28 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US7803753B2 (en) 2005-01-10 2010-09-28 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US8198232B2 (en) 2005-01-10 2012-06-12 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US8030270B2 (en) 2005-01-10 2011-10-04 Arena Pharmaceuticals, Inc. Methods for identifying GLP-1 secretagogues
US8022034B2 (en) 2005-01-10 2011-09-20 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US8003597B2 (en) 2005-01-10 2011-08-23 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
US8017574B2 (en) 2006-04-11 2011-09-13 Arena Pharmaceuticals, Inc. Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues
US8026074B2 (en) 2006-04-11 2011-09-27 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
US8026212B2 (en) 2006-04-11 2011-09-27 Arena Pharmaceuticals, Inc. Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues
US7833730B2 (en) 2006-04-11 2010-11-16 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
US8101626B2 (en) 2006-04-11 2012-01-24 Arena Pharmaceuticals, Inc. GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
US7816364B2 (en) 2006-04-11 2010-10-19 Arena Pharmaceuticals, Inc. GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
US7838254B2 (en) 2008-04-07 2010-11-23 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
US8486646B2 (en) 2008-04-07 2013-07-16 Arena Pharmaceuticals, Inc. Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues
US8883714B2 (en) 2008-04-07 2014-11-11 Arena Pharmaceuticals, Inc. Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

Similar Documents

Publication Publication Date Title
JP2002356472A5 (US07816364-20101019-C00101.png)
US5736549A (en) Hypoxanthine and guanine compounds
ES2327929T3 (es) Derivados de imidazo-piridina como agonistas del receptor de melanocortina.
CA2953132A1 (en) Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JPH06135963A (ja) 置換ベンジルアミノキヌクリジン
PT1689751E (pt) Novas 5,7-diaminopirazolo[4,3-d]pirimidinas com actividade inibidora de pde-5
JPH11500427A (ja) シクロプロピルピロロインドール−オリゴペプチド抗癌剤
JPS5839685A (ja) 新規なカンプトテシン誘導体及びその製造法
JP2007502307A (ja) グルタミン酸ラセマーゼ（ｍｕｒｉ）の阻害剤としての縮合複素環
CA3054324C (en) Tri-cycle compound and applications thereof
TW200418848A (en) Compounds
JP5602731B2 (ja) アーテミシニンの二量体誘導体および抗ガン療法における用途
US6077841A (en) 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
JPS5982384A (ja) 硫黄含有インド−ル誘導体
CA3128435A1 (en) Indolo heptamyl oxime analogue as parp inhibitor
EP0118913A2 (en) Porphyrin derivatives
CN110143974B (zh) 一类新型青蒿素衍生物、合成方法及其用途
JP2021121618A (ja) 狂犬病治療のための環状アミド化合物およびその方法
KR920003927B1 (ko) 헤테로사이클릭구아니딘 5ht_3 길항물질
CA3039407A1 (en) Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof
JP5474820B2 (ja) アルテミシニンの二量体誘導体、および抗癌療法における用途
CN114555607B (zh) 一类靶向蛋白质水解通路的功能分子及其制备和应用
JP2021504455A (ja) トリプトリド誘導体およびその製造方法と使用
ES2232147T3 (es) Derivados de lk6-a.
CN101273044A (zh) 通过二氢吡咯环氧化制备二氮杂并环戊二烯衍生物